Pharmacy Pearls: Ivermectin and COVID

September 7th, 2021 | COVID-19 Pharmacy Pearl•Pharmacy Pearls•Infectious Diseases

This edition of Pharmacy Pearls addresses the alarming rise in outpatient prescribing and dispensing of ivermectin for treatment of COVID-19. There is insufficient evidence at present to support the use of ivermectin to prevent or treat COVID-19, and it can be harmful if taken in inappropriate doses or by inappropriate dosage forms.

If you are looking for a simple way to communicate this information to patients, consider something similar to the following:

“I would not prescribe a drug with no evidence for the treatment of high blood pressure, diabetes, or to treat your pneumonia, and the same goes for COVID-19: I would not prescribe a drug with no evidence relative to COVID-19.”

As always, we welcome any feedback or questions you may have. Just email the Pharmacy Team.

Taking too long?

Reload document

Open in new tab

Download PDF [152.58 KB]

ABI Value	Interpretation	Recommendation
Greater than 1.4	Calcification/vessel hardening	Refer to vascular specialist
1.0 - 1.4	Normal	None
0.9 - 1.0	Acceptable	None
0.8 - 0.9	Some arterial disease	Treat risk factor
0.5 - 0.8	Moderate arterial disease	Refer to vascular specialist
Less than 0.5	Severe arterial disease	Refer to vascular specialist

Pharmacy Pearls: Ivermectin and COVID

Pharmacy Pearls: Ivermectin and COVID

GENERAL COVID-19 INFORMATION